CRYO-CELL International, Inc. (A:CCEL)

Business Focus: Healthcare Facilities & Services

Mar 25, 2024 09:00 am ET
Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value
Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company” or “Cryo-Cell”), the world’s first private cord blood bank to separate and store stem cells in 1992, today announced that its Board of Directors has authorized the spin-off of its newly formed subsidiary, Celle Corp., to the Cryo-Cell shareholders and to explore all strategic alternatives for Cryo-Cell (post spin-off) to maximize shareholder value, including, but not limited to, equity and/or debt financings and/or the possible sale or merger of the company. There is no assurance that such a transaction will take pla
Feb 28, 2024 05:00 pm ET
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023
Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year ended November 30, 2023.
Jan 22, 2024 04:15 pm ET
Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET
Maxim Group LLC, a full-service investment banking, securities and wealth management firm, and M-Vest, a digital community built for issuers, investors, and thought leaders, present the 2024 Healthcare IT Virtual Conference. The conference will...
Oct 12, 2023 04:45 pm ET
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results
Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2023.
Jul 14, 2023 04:15 pm ET
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results
Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31, 2023.
Apr 21, 2023 04:15 pm ET
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial Results
Cryo-Cell International, Inc. (NYSE American LLC: CCEL ) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended February 28, 2023.
Feb 28, 2023 05:15 pm ET
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2022
Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year ended November 30, 2022. Financial Results Revenue...
Jan 24, 2023 11:00 am ET
Maxim Group LLC to Host the Healthcare IT Virtual Conference on Wednesday, January 25th at 8:15 A.M. ET 
Maxim Group LLC, a full-service investment banking, securities and wealth management firm, and M-Vest, a digital community built for issuers, investors, and thought leaders, present the Healthcare IT Virtual Conference. The conference will take...
Oct 14, 2022 04:15 pm ET
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2022 Financial Results
Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2022. Financial...
Aug 22, 2022 06:00 pm ET
Cord Blood Banking Leader Cryo-Cell Announces Special Cash Dividend
Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (“Cryo-Cell”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced today that its Board of Directors declares a one-time, special cash...
Aug 17, 2022 05:00 pm ET
Cord Blood Banking Leader Cryo-Cell Announces Transfer to the NYSE American Stock Exchange
Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (“Cryo-Cell”, the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced today that it will change its listing from the Nasdaq...
Jul 11, 2022 04:30 pm ET
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2022 Financial Results
Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31, 2022. Financial...
Apr 13, 2022 04:30 pm ET
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2022 Financial Results
Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended February 28, 2022....
Mar 16, 2022 04:30 pm ET
Cord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository Service
Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announces it has entered into a purchase contract, with the closing subject to...
Mar 09, 2022 04:15 pm ET
Cryo-Cell Shares Its 2021 Annual Letter to Shareholders
Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, has released its 2021 Annual Letter to Cryo-Cell Shareholders as shown below....
Feb 22, 2022 04:30 pm ET
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2021
Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year ended November 30, 2021. Visit here...
Oct 27, 2021 04:15 pm ET
Cord Blood Banking Leader Cryo-Cell Announces Its Intent to Advance Clinical Trials
Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announces further plans for its newly developed Institute for Cellular...
Oct 15, 2021 04:36 pm ET
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results
Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2021....
Sep 20, 2021 06:05 pm ET
Cryo-Cell International Announces Changes To Its Board of Directors
Cryo-Cell International, Inc. (Nasdaq:CCEL), the leader in cord blood and cord tissue cryopreservation services, announces the appointment of Mr. Mark Portnoy and Mr. Daniel Mizrahi to the Company’s Board of Directors, replacing Mr. George Gaines...
Aug 30, 2021 09:00 am ET
Cryo-Cell International Announces Uplisting to The Nasdaq Capital Market
Cryo-Cell International has met Nasdaq’s stringent financial, liquidity and corporate governance listing requirements. As a result, Cryo-Cell will be listed on Nasdaq as of Tuesday, August 31st 2021. This is expected to improve the liquidity of...
Aug 20, 2021 09:04 am ET
Cryo-Cell International Completes Acquisition of Real Estate Property for Its Institute for Cellular Therapies
Cryo-Cell Institute for Cellular Therapies’ first clinic site is‎ conveniently located in Durham NC, near the Raleigh-Durham International Airport (International Airport). The ‎8,326 sq. ft. facility is well situated, with several nearby hotels to...
Aug 11, 2021 12:03 pm ET
Cryo-Cell International to Present at the Q3 Virtual Investor Summit on August 18, 2021
Oldsmar, Florida--(Newsfile Corp. - August 11, 2021) - Cryo-Cell International (OTC Pink: CCEL) today announced that David Portnoy, Chairman of the board and Co-CEO will be attending the Q3 Virtual Investor Summit.
Aug 11, 2021 09:00 am ET
Cryo-Cell International to Present at the Q3 Virtual Investor Summit
Cryo-Cell International announces that Chairman of the Board and Co-CEO, David Portnoy, will be presenting at the Q3 Virtual Investor Summit on August 18th, 2021. David Portnoy, Chairman of the Board and Co-Chief Executive Officer of Cryo-Cell...
Aug 11, 2021 07:00 am ET
Cryo-Cell International to Present at the Q3 Virtual Investor Summit
Oldsmar, Florida--(Newsfile Corp. - August 11, 2021) - Cryo-Cell International (OTC Pink: CCEL) today announced that David Portnoy, Chairman of the board and Co-CEO, will be attending the Q3 Virtual Investor Summit.
Jul 15, 2021 07:27 pm ET
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2021 Financial Results
Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31, 2021. Financial...
May 10, 2021 09:00 am ET
Cryo-Cell International Proudly Announces Two Ongoing COVID-19 Related Trials
Cryo-Cell’s Medical Director, Dr. Joanne Kurtzberg and her research team at The Marcus Center for Cellular Cures (MC3) at Duke University School of Medicine are currently conducting two major studies: MASC (Phase 1/2) & MISTIC (Phase 1) to treat,...
Apr 14, 2021 06:13 pm ET
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2021 Financial Results
Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended February 28, 2021....
Feb 26, 2021 09:30 am ET
Cord Blood Banking Leader Cryo-Cell International Enters Into An Exclusive License Agreement with Duke University
Cryo-Cell International, Inc. (symbol: CCEL), the world’s first private cord blood bank to separate and store stem cells, has entered into a collaborative license agreement with Duke University. The agreement grants Cryo-Cell the rights to...
Feb 24, 2021 04:30 pm ET
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2020
Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year ended November 30, 2020. Financial Results...
Oct 15, 2020 04:39 pm ET
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2020 Financial Results
Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2020. Financial...
Jul 10, 2020 05:41 pm ET
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2020 Financial Results
Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31, 2020.  Financial...
Jun 11, 2020 04:10 pm ET
Cord Blood Banking Leader Cryo-Cell Enters into Patent Option Agreement with Duke University
Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced that effective June 9, 2020, the Company has entered into a patent...
Apr 14, 2020 04:30 pm ET
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2020 Financial Results
Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended February 29, 2020....
Feb 27, 2020 05:09 pm ET
Cryo-Cell Reports Financial Results For Fiscal Year Ended November 30, 2019
Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year ended November 30, 2019. Financial Results...
Oct 15, 2019 04:30 pm ET
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2019 Financial Results
Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2019....
Jul 15, 2019 04:15 pm ET
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2019 Financial Results
Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31, 2019.  Financial...
Apr 15, 2019 04:15 pm ET
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2019 Financial Results
Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended February 28, 2019....
Feb 28, 2019 04:05 pm ET
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2018
Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year ended November 30, 2018. Financial Results...
Oct 15, 2018 05:00 pm ET
Cryo-Cell Reports Fiscal Third Quarter 2018 Results
Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2018. Financial...
Jul 16, 2018 05:00 pm ET
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2018 Financial Results
Cryo-Cell International, Inc. (OTCQB:CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31, 2018.  Financial Results Revenue...
Jun 15, 2018 09:00 am ET
Cryo-Cell Consummates Acquisition of CORD:USE Assets and Extends Its Leadership Position Into the Public Cord Blood Banking Arena
Cryo-Cell International, Inc. (OTCQB:CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced that it has completed its acquisition of  substantially all of the assets of CORD:USE Cord...
Jun 04, 2018 09:00 am ET
Cord Blood Banking Leader Cryo-Cell Acquires CORD:USE Cord Blood Bank, Inc.
Cryo-Cell International, Inc. (OTCQB:CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced that it has entered into an agreement (the “Asset Purchase Agreement”) to acquire...
Apr 16, 2018 05:15 pm ET
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2018 Financial Results
OLDSMAR, Fla., April 16, 2018 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTCQB:CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended February...
Feb 28, 2018 04:15 pm ET
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2017
OLDSMAR, Fla., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTCQB:CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year ended November 30,...
Jul 07, 2017 04:30 pm ET
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2017 Financial Results
OLDSMAR, Fla., July 07, 2017 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTCQB:CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31, 2017. ...
Apr 14, 2017 04:00 pm ET
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2017 Financial Results
OLDSMAR, Fla., April 14, 2017 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTCQB:CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended February 28, 2017.  ...
Feb 28, 2017 05:53 pm ET
Cryo-Cell Reports Financial Results for Fiscal 2016
OLDSMAR, Fla., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTCQB:CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year 2016.  ...
Oct 18, 2016 05:00 pm ET
Cryo-Cell Reports Fiscal Third Quarter 2016 Results
OLDSMAR, Fla., Oct. 18, 2016 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (the “Company”) (OTC:QB Markets Group Symbol:CCEL), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2016....
Jul 11, 2016 04:30 pm ET
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2016 Financial Results
OLDSMAR, Fla., July 11, 2016 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol:CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31, 2016. ...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.